Influenza is a viral infection that is constantly changing. It has not been discovered yet the exact way that viral infections like these are becoming drug resistant without waiting for new and untreatable strains arise. Using a novel genetic screen, researchers at the University of California have mapped out the resistance options of influenza's M2 channel against its anti-viral medication inhibitors. This allows the clinically known resistant mutations to be identified without contamination from outside sources. This led to novel mutations that were known to exist in viruses but not to be drug resistant. The same methods were used against a drug that has not been put out on the market yet for clinical use. This enabled the researchers to identify more new resistance mutations. This research will allow new antiviral agents to be tested to predict the resistance options before clinical use.
Read more at: http://www.sciencedirect.com/science/article/pii/S0022283616303023
Molecular Biology
Sunday, November 27, 2016
Monday, November 14, 2016
Construction and Rescue of a Molecular Clone of Deformed Wing Virus (DWV)
The problem of honey bees being endangered has been brought to light a lot more in social media and the news lately. Honey bees are extremely important in the agriculture business and human nutrition. Deformed wing virus (DWV) is playing a major role in the colony mortality but not much is known about this virus. This virus comes from Varroa jacobsoni mite infestations which has been spread to every continent but Australia due to colony trade. The University of Vienna is trying to close the gap between field research and lab findings to complete an in-vitro model. At this point, colony survival depends on close supervision and help. Once a colony shows DWV symptoms, the colony is more than likely going to fail. DWV can lead to crippled wings and discoloration. A genomic sequence of DWV has been known since 2006 but there are a limited number of tools that are available for studying bee viruses in the lab. The researchers took infectious DWV from a molecular clone that produces DWV symptoms. Through newly made anti-AWV monoclonal antibodies, expression of DWV proteins, producing the virus' progeny, and host cell tropism could be confirmed. Koch's postulates were fulfilled so the virus did not need to be isolated and purified. From this research, a reverse genetics system was developed and applied for DWV pathogenesis. This provides a new basis to study the unknown aspects of DWV along with the molecular mechanisms behind transmission. This study covered the preliminary background needed to continue research to hopefully find a way to minimize the transmission of DWV before honey bees become extinct.
Wednesday, November 9, 2016
Scientists Find Key Protein For Spinal Cord Repair
Zebrafish have the ability to heal their own spinal cord after it has been severed which is definitely not something humans are capable of. Researchers at Duke found the specific protein that plays a major role in this process. This discovery can be a major one towards applying it to people. When the fish's spinal cord is severed, a bridge is formed. First wells extend and connect the gap then nerve cells follow. By 8 weeks the injury is completely healed and the fish has its normal capabilities again. To determine which genes were changed, the scientists monitored the activity of the genes that had large changes once damage was done to the spinal cord. CTGF or connective tissue growth factor is a gene coded for proteins that is secreted from cells. The levels of this rose in the cells that formed the bridge. When CTGF was deleted, the fish were not able to regenerate. The human CTGF protein is extremely similar (almost 90%) in the amino acid make up to the zebra fish. When human CTGF was added to the fish, regeneration was faster. Since healing is more complex in mammals due to the scar tissue, the scientists do not think CTGF alone is sufficient enough to regenerate in people. The next step mice and when the CTGF levels are the highest. At this point, the scientists are believing that it is how the protein is controlled and not the actual make up.
Read more at: https://today.duke.edu/2016/11/scientists-find-key-protein-spinal-cord-repair
Read more at: https://today.duke.edu/2016/11/scientists-find-key-protein-spinal-cord-repair
Saturday, October 29, 2016
Therapeutic reversal of food allergen sensitivity by mature retinoic acid–differentiated dendritic cell induction of LAG3+CD49b−Foxp3− regulatory T cells
As someone who has a food allergy to the most random things, I found this research to be super exciting. Anaphylaxis can be life threatening and there isn't really a cure found yet. Regulatory dendritic cell therapy has been effective in mice with allergic disease and has worked with cells from atopic asthmatic patients. So far, it has been found that DC immunotherapy can be effective in reversing food allergies through the operative mechanism.
More can be read at: http://www.jacionline.org/article/S0091-6749(16)30969-1/abstract
More can be read at: http://www.jacionline.org/article/S0091-6749(16)30969-1/abstract
Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice
If it were possible to live a much longer life, would you take the opportunity? Researchers at Washington University School of Medicine are working on a way to do this. NAD+ availability decreases as a person ages or when they get certain diseases. Nicotinamide mononucleotide or NMN is a NAD+ intermediate that can enhance NAD+ biosynthesis in mice. When mice were administered NMN over a 12 month period, NAD+ was quickly synthesized which reduces age-associated physiological decline. The age-associated gene expression changes in certain organs was also prevented. Instead of the mice just keeping what appears to be a steady age, the mice were actually doing the opposite of aging. This research would have to be tested much further until it was applied to humans but it showed no toxicity in the mice tested. This could be a really good thing for people with life threatening disease but can also be abused.
To read more: http://www.cell.com/cell-metabolism/pdf/S1550-4131(16)30495-8.pdf
To read more: http://www.cell.com/cell-metabolism/pdf/S1550-4131(16)30495-8.pdf
Monday, October 17, 2016
New Molecular Biology Technique Could Help Identify Virus-Fighting Potential of Existing Drugs
According to a study reported in PLOS Computational Biology, a new molecular biology technique can be used to identify the virus-fighting potential of existing drugs designed to treat other conditions. Researches at Vanderbilt have developed a strategy to identify drugs with the potential to fight other deadly viral infections. Gene-trap insertional mutagenesis is being used to identify genes that allow viruses to take over human cells but are not necessary for cell survival. Next, a computational framework was used to screen existing drugs that effect these genes. There were 110 genes that produce proteins that could serve as targets for existing drugs. Many of these genes were involved in HIV-1 and Ebola. So far, it was found that the anti-arrhythmia drug ajmaline as a potential Ebola treatment. This method still has a lot of research to be done and many trials to go through before it can actually be used but I believe that it is a good start. By using drugs that have known effects, known side effects, and are already approved for treatment for other conditions could be a very big advancement in the medical field. Instead of having to do massive amounts on research for a new treatment and for the treatment to be specifically designed for one virus such as Ebola, it would be a time saver to just use known drugs.
Read more at: http://www.news-medical.net/news/20161003/New-molecular-biology-technique-could-help-identify-virus-fighting-potential-of-existing-drugs.aspx
Read more at: http://www.news-medical.net/news/20161003/New-molecular-biology-technique-could-help-identify-virus-fighting-potential-of-existing-drugs.aspx
Saturday, October 8, 2016
Newborn Gut Microbiome Predicts Later Allergy and Asthma, Study Finds
Allergy season is here unfortunately but what if the microbes in your gut during the first month of life determine your risk of having allergies or asthma later in life? Researchers at the University of California in San Francisco and the Henry Ford Health System in Detroit have studied this and the results show that certain gut microbes in infants increase the risk of allergies and asthma later in childhood. It was found that a molecule that reduce the abundance of a certain immune cell that prevents allergies were present in at-risk babies. The only other strong links found between allergies and asthma were males were more likely to be affected and having a dog in the household actually lowered the risk of allergies and asthma. Could the microbes in these baby's gut be altered so that they will not have such a high risk of having allergies or asthma later in life?
Read more at: https://www.ucsf.edu/news/2016/09/404071/newborn-gut-microbiome-predicts-later-allergy-and-asthma-study-finds
Read more at: https://www.ucsf.edu/news/2016/09/404071/newborn-gut-microbiome-predicts-later-allergy-and-asthma-study-finds
Subscribe to:
Comments (Atom)